• Latest Posts

Italian study shows CRISPR/Cas9 deletion of Interleukin-30 reduces prostate cancer growth

Reveal Genomics reveals more HER2DX breast cancer validation data

Santhera and ReveraGen announce first patient with Becker muscular dystrophy dosed in FDA-funded pilot study

New partnership delivers clinically proven products and manufacturing processes for advanced therapies

AGC Biologics announces gene therapy partnership with Altheia Science

Forcefield Therapeutics Launched to Treat Heart Attacks with Protein Drugs


Two Gene Therapy Players Launch IPOs on Stormy Stock Market

Engitix Builds Liver Disease Pipeline with Series A and Drug Collaboration

Sofinnova Taps into Italian Gene Therapy with Three Seed Financings

Record Series A for Italian Biotech Funds Autoimmune Therapy

Italian Pharma Getting Back to Normal With Two Biotech Acquisitions

Sofinnova Invests €20M in Three Italian Rare Disease Biotechs